Learning Objectives:

1. Describe the findings for draft ERAS and clinical care guidelines
2. Summarize the questions considered by the guidelines author team
3. Explain the best practice recommendation for at least two of the draft guidelines for critical care

Join your colleagues for this webinar focused on the nutrition care of adult oncology patients. The faculty will address nutrition screening and assessment, including available screening tools for both inpatient and outpatient assessment. Faculty will address cancer cachexia, including etiology and American Society of Clinical Oncology (ASCO) guidelines regarding diagnosis and management. Lastly, controversies surrounding nutrition support, including indications, role in tumor growth and use in a palliative setting will be covered. You will not want to miss this comprehensive program.

Learning Objectives:

• Review options for nutrition screening for inpatient and outpatient oncology patients
• Discuss recent guidelines for managing cancer cachexia
• Recognize controversies associated with nutrition support in patients with cancer

Several new intravenous lipid emulsions (ILE) have been approved by the FDA for adults receiving parenteral nutrition, providing a source of calories and essential fatty acids when nutritional needs cannot be met via the enteral route. With new ILEs available, clinicians must understand key differences between ILEs, available evidence, and the impact new ILEs may have on patient outcomes. This webinar will compare and contrast the available ILEs in the US. A discussion of the results of a retrospective study completed at a large US academic medical center evaluating clinical outcomes of soy-oil based ILE compared to a multi-oil ILE will follow. The speakers will then discuss how data was used to effect formulary changes at their institution.

Learning Objectives:

• Compare and contrast available intravenous lipid emulsions (ILE) in the US market.
• Discuss the evidence for use of new ILEs in clinical care with a focus on optimizing outcomes.
• Share recent data from a large institutional study which evaluated clinical outcomes during a switch from a soy oil based ILE to a multi-oil ILE.
• Discuss rationale, pathway, and key evidence for proposing/justifying conversion to new ILE within your institution.

This webinar will highlight nutrition assessment components, review nutrition support practices, and describe nutritional implications associated with gastrointestinal GVHD in hematopoietic cell transplantation (HCT) recipients. Patients undergoing HCT are a highly heterogenous population in terms of their nutrient needs and requirement for nutrition intervention. The implications of dose-intensive conditioning regimens, coupled with the debilitating effects of graft-versus-host disease (GVHD), can be extremely complex and adversely effect a patient's nutritional status. Decreased oral intake, increased nutrient requirements, and impaired nutrient utilization often necessitate medical nutrition therapy. The use of standard supportive care measures, including parenteral nutrition and enteral nutrition, have varied over the past four decades and are highly dependent upon the type of transplant being utilized.

Learning Objectives:

• Identify necessary components of a comprehensive nutritional assessment for patients undergoing hematopoietic cell transplantation
• Construct appropriate nutritional plan of care for patients undergoing hematopoietic cell transplantation
• Describe nutritional implications associated with gastrointestinal graft versus host disease

This 3-hour virtual course will provide clinicians an opportunity to be updated on the available nasoenteric tube placement technologies, and the recommended methods for tube verification and securement. A focus of the course will be to compare and contrast the available technologies from a safety and clinical applicability aspect. The last part of the course will discuss the ASPEN recommendations for a clinician competency program for the placement and verification of nasoenteric tubes in adults. The course supports the recent ASPEN Best Practices publication “ Development of a Competency Model for Placement and Verification of Nasogastric and Nasoenteric Feeding Tubes for Adult Hospitalized Patients” (Nutrition in Clinical Practice, June 2021).

Part 1: Nasoenteric Tube Placement (90 minutes)

Part 1 will consist of five (5) 10-minute presentations. The first one is on blind tube placement by a clinician which will be followed by 4 manufacturers of enteral tube placement technologies. These presentations will be followed by a discussion of the technologies from a safety and clinical applicability perspective by an expert panel. The session will conclude with a 15-minute question and answer session.

Learning Objectives

1. Identify the currently available enteral tube placement technologies.
2. Summarize important safety concerns with enteral tube placement.
3. Compare and contrast the available enteral tube placement technologies.

Faculty and Topics
Blind Placement Video
Christina M. Rollins, MBA, MS, RDN, LDN, FAND, CNSC

Expert Panel Discussion

• Mark H. DeLegge, MD, FACG, CNSP, AGAF, FASGE
• Jan Powers, PhD, RN, CCNS, CCRN, NE-BC
• Britta Brown, MS, RD, LD, CNSC
• Arlene A. Escuro, MS, RD, LD, CNSC, FAND, FASPEN

Sponsoring companies’ representatives:

• Avanos
• Cardinal Health
• ENvizion Medical Inc.
• PatCom Medical Inc.

Part 2: Nasoenteric Tube Verification and Securement (45 minutes)

Part 2 will include three (3) short (10-12 minute) presentations demonstrating the currently available enteral tube verification and securement methods, followed by an expert panel discussion and question and answer session.

Learning Objectives

1. Identify currently available enteral tube verification and securement methods.
2. Summarize the important safety concerns with enteral tube verification methods.

Faculty and Topics
Xray Verification
Mark H. DeLegge, MD, FACG, CNSP, AGAF, FASGE

pH, Electromagnetic, CO2, and Other Verification
Beth Lyman, MSN, RN, CNSC, FASPEN, FAAN

Securement
Carol McGinnis, DNP, APRN

Expert Panel Discussion

• Mark H. DeLegge, MD, FACG, CNSP, AGAF, FASGE
• Beth Lyman, MSN, RN, CNSC, FASPEN, FAAN
• Carol McGinnis, DNP, APRN-CNS, CNSC

Part 3: Clinician Competency (45 minutes)

Learning Objectives

1. Describe the ASPEN nasoenteric tube placement competency model.
2. Describe the importance of a clinician competence model for the safe placement of nasoenteric tubes.
3. Implement the ASPEN competency model in the practice setting.

Faculty and Topics
Need for Competency
Britta Brown, MS,RD, LD, CNSC

Use of ASPEN Competency Tool
Jan Powers, PhD, RN, CCNS, CCRN, NE-BC

Workshop Moderator
Peggi Guenter, PhD, RN, FAAN, FASPEN

This program is not available for CE credit.

You will not want to miss this interdisciplinary panel of experts discuss nutrition management of challenging patient cases. The faculty will discuss the nuances in providing optimal evidence-based care with a focus on complex critically ill transplant, gastroenterology and oncology patients.

Learning Objectives:

• Describe the challenges in providing nutrition therapy for a critically ill heart transplant patient and discuss strategies to optimize nutrition interventions.
• Describe the challenges in providing nutrition therapy for an outpatient gastroenterology patient and how to optimize nutrition interventions.
• Describe the challenges in providing nutrition therapy for an oncology patient and the best strategies to implement for optimal nutrition interventions.
  

Long COVID is seen when symptoms persist longer than 30 days. The pleasure of eating is affected by persistent nausea and dysgeusia, in addition to other metabolic alterations or consequences of the acute phase of illness, which can lead to malnutrition. This presentation focuses on the epidemiology and pathophysiology of long COVID and addresses its nutritional consequences and potential treatment options. It is a very timely topic as we all continue to struggle to optimally treat our patients with COVID.

Learning Objectives:

• Review the epidemiology and pathophysiology of long COVID.
• Identify the nutrition complications of long COVID, including anosmia and dysgeusia.
• Examine the role of nutritional supplements in the prevention and treatment of long COVID.
• Discuss the nutritional components of persistent inflammation, immunosuppression, and catabolism

Financial support provided by Nestlé Health Science.

CE is available through Nestlé Health Science.

Nestlé Health Science is a Continuing Professional Education Accredited Provider with CDR, the credentialing agency for the Academy of Nutrition and Dietetics. Accredited provider number NE008.

RDs and DTRs practicing in the US may log CPE activities under Activity Type 175 for up to three years from the original presentation date. This program is eligible for 1.5 CPEUs. The activity number for viewing this recording through May 31, 2024 is 168469 (level 2).

To learn more about submitting this activity type visit https://www.cdrnet.org/new-recorded-preapproved-CPE-activity-type

To obtain a CE certificate, login or register at www.nestlemedicalhub.com/myce/welcome

Once logged in, go to https://www.nestlemedicalhub.com/myce/pin

1) Enter PIN code: 559C4137 in the box provided.

2) Select "Submit"

3) Complete the evaluation for this activity and select “Submit”

4) Select the Dietitian or Attendance certificate type in the drop-down box, enter your professional ID or registration number and click "Print Certificate." The certificate can be saved to your personal computer and/or printed.

Please send questions about claiming CE to MyCE@us.nestle.com

Management of patients with short bowel syndrome with intestinal failure not only necessitates a strong knowledge of intestinal physiology, enteral, and parenteral nutrition support, but also the role of GLP-2 peptides. With several new GLP-2 analogs in drug development, it is also critical to understand the role of GLP-2 peptides and if/when they might be beneficial for your patients. This webinar will review the role of GLP-2 peptides in intestinal physiology and the mechanism of action of the drug analogs. It will also address the lessons learned over the last 10 years and prospects for the future.

Learning Objectives:

• To understand the role of GLP-2 peptide in digestion, absorption and nutrition and the mechanism of action of GLP-2 analogs in short bowel syndrome with intestinal failure (SBS-IF).
• To learn the lessons during the last 10 years since the first GLP-2 analog was developed and how new trials have incorporated a personalized anatomy approach when treating SBS-IF patients.

Join Patient Advocate/Researcher, Swapna Kakani and Clinician/Scientist, Dr. Marion Winkler as they host a fireside chat on life with Short Bowel Syndrome–Intestinal Failure (SBS-IF). They will discuss what factors are associated with higher and lower patient reported quality of life, as well as strategies to use in practice to help focus on aspects of care associated with well-being and adaptation while living with SBS-IF.

Learning Objective:

1. Identify factors that affect quality of life of patients with SBS-IF.
2. Describe research results and anecdotes of patient experiences, models of care and resources to help improve adaptation to life with SBS-IF.
3. Implement strategies for improved patient/clinician communication and shared decision making.

This non-accredited program is sponsored by

There is a need for best practice recommendations for the use of supplemental parenteral nutrition (PN). The speakers will share their expertise on use of supplemental PN in surgical oncology patient populations, including when to use initiate it and how best to manage these patients who may receive supplemental PN. A case-based global approach will be employed using an international panel of experts.

Learning Objectives:

• Define supplemental PN as part of the nutritional regimen in surgical oncology patients.
• Review the indications for supplemental PN in surgical oncology patients.
• Outline the optimal management of supplemental PN in surgical oncology patients.

This non-accredited program is sponsored by